Products

Ramoplanin

Product Information

Cat #

MFTP-059

CAS No.

76168-82-6

Enzyme Commission Number

Product Overview

Its development has been fast-tracked by the U.S. Food and Drug Administration as a treatment for multiple antibiotic-resistant Clostridium difficile infection of the gastrointestinal tract, Unlike vancomycin, it is absorbed in the gastrointestinal tract, although it is unstable in the bloodstream, so can be taken only orally against Clostridium difficile infections of the gastrointestinal tract.

Features

Ready-to-use product, accelerating research progress, enhancing application performance.

Method

Technology

Synonyms

Type

Function

Applications

Industrial Applications

Storage

Storage Buffer

Shelf Life

Strains

Actinoplanes spp.

Source

Appearance

Molecular Weight

Color / Form

Instruction

Enzyme Class

Production Methods

Fermentation

Activity

Specific Enzyme Activity

Purity

Unit Definition

Amino Acids Sequence

WARNINGS

Shipping

Timely shipping by optional means

Formula

Reaction

Recommendation

Species Reactivity

Contents

Compatibility

Melting Point

Final Titre

2±0.2g/L

Fermentation Time

216±12hrs

Recovery Yield

≥50%

Starting Material

Specification

Standard and Custom Specifications

Substrates

Concentration

Usage And Dosage

Description

Ramoplanin exerts its bacteriocidal effect by inhibiting cell wall biosynthesis, acting by inhibiting the transglycosylation step of peptidoglycan synthesis.

For Research Use Only.

Have a question? Get a Free Consultation